Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.800
+0.450 (10.34%)
Jul 14, 2025, 4:00 PM - Market closed
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $628.91 million as of July 14, 2025. Its market cap has decreased by -7.65% in one year.
Market Cap
628.91M
Enterprise Value
587.46M
1-Year Change
-7.65%
Ranking
Category
Stock Price
$4.80
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $628.91M, a decrease of -61.36%. That is a compound annual growth rate of -29.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 569.95M | 52.97% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |